Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie AdamsOn the same day that health and wellness supplement provider Hims & Hers Health, Inc. announced it would begin selling a compounded semaglutide pill for weight loss at $49 for the first month, Novo Nordisk on Feb. 5 said it would take legal and regulatory action against the company for infringement of its intellectual property.Novo Nordisk has manufactured its injectable drug Wegovy for weight loss since 2021 and announced on Jan. 5 that it would distribute the popular GLP-1 weight-loss drug as a daily oral pill.
-12.8
C
Ottawa
Thursday, February 5, 2026
The Alliance Press is the world leader in online chained news and information and seeks to inform, engage and empower the world. We expose the information that wasn't known before or current events broadcast over the radio, television, online or in print media. Our content is now available through your mobile phone. No matter where your on-the-go lifestyle takes you, TAP brings the news directly to you.
More from CN
Contact
© The Alliance Media Group design by CODEUS